Trade & Transaction Reporting Services

Identify failings in the completeness, accuracy, and timeliness of your MiFID/MiFIR and EMIR regulatory reporting with our team of experts.

The requirement to report details of transactions has existed for many years but, as regulations have evolved, this has become increasingly onerous and complex. The FCA has identified improved regulatory reporting as one of its supervisory priorities, having already levied fines of varying sizes totaling more than £130m for reporting errors or omissions under MiFID and EMIR.

Our award-winning trade and transaction reporting solutions help your firm identify failings in the completeness, accuracy, and timeliness of your trade and transaction reports. The prompt identification of errors can significantly reduce the cost and reputational risk from regulatory scrutiny and enforcement as well as the operational burden of re-reporting.

Book A Free Review


Book A Free Review


Our solutions

Systems and Controls Reviews

For one-off or recurring reviews of the controls surrounding your firm’s reporting framework.

By looking at both the design and operation of those controls, we help ensure that you have the appropriate monitoring, oversight and governance arrangements in place to facilitate correct reporting. These reviews are available for a combination of reporting regimes, in addition to the ARRMA service or as a standalone service.

Click here to speak to an expert

For a regular, cost-effective solution to analyse the data included in your firm’s reports and identify issues relating to the accuracy, completeness and timeliness.

By blending technology with consulting services, our award winning solution helps firms undertake meaningful monitoring that would otherwise require intensive, expensive and burdensome internal resources. Our reviews can be conducted monthly or quarterly with costs determined on a sliding scale to reflect report volumes.

Learn more

Training

We provide training for topics including transaction reporting, EMIR, market abuse, trade surveillance, senior management obligations, governance and compliance officer roles and responsibilities.

These are delivered by one of our specialist trainers and can be customised to meet your firm’s needs.

Click here to view our training options

1 of
Solution Spotlight

Free transaction reporting review

Take advantage of a complimentary one-time ARRMA lite reporting analysis to help identify the percentage of your reports featuring an error.

97% of firms analysed by our award-winning ARRMA service have shown errors in their reporting* and many firms are still in breach by not incorporating market data processor (MDP) data in their MiFIR transaction reporting monitoring.

Book your free review to assess the state of your transaction reporting today.

Our team

Charlotte Longman

Charlotte Longman

Managing Director and Lead, ACA's Regulatory Reporting & Assurance (ARRMA) Service
Headshot of Andrae Young

Andraé Young

Principal Consultant
1 of

Why work with us?

Our deep expertise

Our deep expertise in compliance and market surveillance technology can help strengthen your trade and transaction reporting programme, identify potential business and compliance risks, and avoid potential problems arising with key stakeholders, regulators, and current and prospective clients.

Our specialist team

Our specialist team has performed numerous EMIR and MiFIR reviews, from high-level control testing to full scope data analysis, logic specification and control design projects.

Our insights and benchmarking

We provide insights from quantitative ARRMA peer analysis to help you understand how your firm compares to its industry peers. This benchmarking is a valuable addition to your firm’s management body reporting as part of ongoing governance.

Latest trade and transaction reporting insights

Architectural image - office windows

New Research Shows That 97% of Firms are Reporting Incorrectly Under MiFIR/EMIR

Recent research and analysis shows 97% of reports under MIFIR/EMIR contain inaccuracies, on average each report has 30 separate error types. But worryingly, despite this, 87% of firms are confident in the quality of their reports. On the anniversary of EMIR REFIT, data quality is still poor

Press Release
  • Compliance
  • Trade & Transaction
  • Managed Services
  • ACA News
Globe image

Navigating Evolving Risks on the Regulatory Horizon

Regulatory change, COVID-19 fallout, and a rapidly mutating ecosystem of risks make this a challenging year for financial services firms. In our complimentary whitepaper, we examine the future of risk and compliance and how firms must respond to rapidly evolving circumstances.

Article
  • Trade & Transaction
  • Compliance
  • ESG
  • Managed Services
  • Regulatory Deadlines
  • RegTech
  • ComplianceAlpha
  • FCA
  • SEC
  • Cybersecurity
  • RiskMutation
  • Brexit
  • COVID-19
  • GIPS Standards
  • Mirabella
highway at night from overhead

ESMA final report recommends expansion of transaction reporting regime to AIFMS and UCITS Management Companies

ESMA has published a final report assessing the functioning of the Transaction Reporting regime under Article 26 of the Markets in Financial Instruments Regulation (“MiFIR”). Among a number of proposed changes perhaps the most impactful is the recommendation that UCITS management companies and AIFMs that are providing one or more MiFID services (i.e., Collective Portfolio Management or ‘CPMI’ firms) should be subject to transaction reporting

Article
  • Trade & Transaction
  • Compliance
city skyline from above

Trade and Transaction Reporting: Fast is Fine, but Accuracy is Everything

The accuracy and quality of trade and transaction reports under MiFIR, EMIR and SFTR are a continuing source of regulatory concern, but voluminous and significant errors are still common. We examine how firms can better tackle regulatory reporting obligations.

Report
  • Trade & Transaction
highway at night from overhead

Trade and Transaction Reporting: Perfect Storm or Opportunity Knocking?

As geopolitical change and uncertainty, regulatory sabre-rattling and industry shake-ups combine to create a perfect storm, we examine the impact for financial services firms on their trade and transaction reporting obligations under MiFIR, EMIR and SFTR.

Article
  • Compliance
  • Trade & Transaction
curved glass building looking up at a blue sky

New Focus on Senior Manager Responsibility for Regulatory Reporting

Regulators are placing increasing importance on senior managers taking personal responsibility and accountability for regulatory reporting under SM&CR. We examine what this means for firms in scope of the MiFIR, EMIR or SFTR reporting regime.

Compliance Alert
  • Trade & Transaction

Featured webcasts

MiFIR Transaction Reporting: A Practical Guide

Join us on Monday, 19 July at 11:00am BST for a complimentary webcast to mark the forthcoming launch of AIMA’s MiFIR Transaction Reporting Guide that has been developed with the support of ACA Group.

Webcast

EMIR Refit: Reporting Checklist

The most recent phase of the amended European Market Infrastructure Regulation (“EMIR REFIT” or simply “REFIT”) came into effect on 18 June 2020. These latest requirements are designed to simplify a derivatives regime currently seen as burdensome to some market participants, particularly those whose risk profile is unlikely to impact macro stability.

Webcast

News

Apex Group and ACA Form Strategic Partnership to Enhance Client Experience

Apex Group and ACA form strategic partnership to enhance client experience. The alliance enables clients to seamlessly identify a reputable service provider that will help support and protect their business.

ACA's Commitment to Client Success Deepens with the Appointment of New COO

ACA Group is delighted to announce the appointment of Jean-Christophe Chandumont (JC) as Chief Operating Officer.

ACA and ACA ALLiance Celebrate Pride and Progress

This Pride Month, we are excited to celebrate with our employee resource group, ACA ALLiance, to honor the contributions and experiences of the LGBTQIA+ community within ACA and beyond.